Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

Laboratory assay measurement of modified clotting factor concentrates: a review of the literature and recommendations for practice.

Young GA, Perry DJ; International Prophylaxis Study Group (IPSG).

J Thromb Haemost. 2019 Apr;17(4):567-573. doi: 10.1111/jth.14394. Epub 2019 Feb 17. Review.

PMID:
30667575
2.

Thromboelastography and thrombin generation assay in inherited afibrinogenemia.

Young GA, Carmona R, Cano Garcia V.

Haemophilia. 2018 Nov;24(6):e410-e416. doi: 10.1111/hae.13620. Epub 2018 Oct 21.

PMID:
30345592
3.

An atom probe perspective on phase separation and precipitation in duplex stainless steels.

Guo W, Garfinkel DA, Tucker JD, Haley D, Young GA, Poplawsky JD.

Nanotechnology. 2016 Jun 24;27(25):254004. doi: 10.1088/0957-4484/27/25/254004. Epub 2016 May 16.

PMID:
27181108
4.

Contribution of Accelerated Degradation to Feedback Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Cholesterol Metabolism in the Liver.

Hwang S, Hartman IZ, Calhoun LN, Garland K, Young GA, Mitsche MA, McDonald J, Xu F, Engelking L, DeBose-Boyd RA.

J Biol Chem. 2016 Jun 24;291(26):13479-94. doi: 10.1074/jbc.M116.728469. Epub 2016 Apr 29.

5.

Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE).

Valentino LA, Walsh CE, Reding MT, Young GA, Levendoglu-Tugal O, Cooper DL.

Haemophilia. 2012 Jul;18(4):554-60. doi: 10.1111/j.1365-2516.2012.02762.x. Epub 2012 Feb 20.

PMID:
22348407
6.

Ab initio calculations for industrial materials engineering: successes and challenges.

Wimmer E, Najafabadi R, Young GA Jr, Ballard JD, Angeliu TM, Vollmer J, Chambers JJ, Niimi H, Shaw JB, Freeman C, Christensen M, Wolf W, Saxe P.

J Phys Condens Matter. 2010 Sep 29;22(38):384215. doi: 10.1088/0953-8984/22/38/384215. Epub 2010 Sep 7.

PMID:
21386549
7.

Targeting chronic myeloid leukemia stem cells.

Helgason GV, Young GA, Holyoake TL.

Curr Hematol Malig Rep. 2010 Apr;5(2):81-7. doi: 10.1007/s11899-010-0043-0. Review.

PMID:
20425400
8.

Clinical perspectives in lymphoma.

Young GA, Iland HJ.

Intern Med J. 2007 Jul;37(7):478-84. Review.

PMID:
17547725
9.

Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.

Belov L, Mulligan SP, Barber N, Woolfson A, Scott M, Stoner K, Chrisp JS, Sewell WA, Bradstock KF, Bendall L, Pascovici DS, Thomas M, Erber W, Huang P, Sartor M, Young GA, Wiley JS, Juneja S, Wierda WG, Green AR, Keating MJ, Christopherson RI.

Br J Haematol. 2006 Oct;135(2):184-97. Epub 2006 Aug 25.

PMID:
16939496
10.

Lymphoproliferative disorders.

Young GA.

Pathology. 2005 Dec;37(6):407-8. No abstract available.

PMID:
16373223
11.

Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome.

Grewal SS, Wynn R, Abdenur JE, Burton BK, Gharib M, Haase C, Hayashi RJ, Shenoy S, Sillence D, Tiller GE, Dudek ME, van Royen-Kerkhof A, Wraith JE, Woodard P, Young GA, Wulffraat N, Whitley CB, Peters C.

Genet Med. 2005 Feb;7(2):143-6.

PMID:
15714083
12.

A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.

Bradstock KF, Matthews JP, Lowenthal RM, Baxter H, Catalano J, Brighton T, Gill D, Eliadis P, Joshua D, Cannell P, Schwarer AP, Durrant S, Gillett A, Koutts J, Taylor K, Bashford J, Arthur C, Enno A, Dunlop L, Szer J, Leahy M, Juneja S, Young GA; Australasian Leukaemia and Lymphoma Group.

Blood. 2005 Jan 15;105(2):481-8. Epub 2004 Jun 22.

13.

Unusual case of subcutaneous panniculitis-like T-cell lymphoma.

Wells J, Kosky CA, Scolyer RA, Lee S, Bye PT, Young GA, Davies L.

Australas J Dermatol. 2004 May;45(2):114-8.

PMID:
15068459
14.

Receptive and expressive language skills of children with five years of experience using a cochlear implant.

Young GA, Killen DH.

Ann Otol Rhinol Laryngol. 2002 Sep;111(9):802-10.

PMID:
12296335
15.

Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia.

Matthews JP, Bishop JF, Young GA, Juneja SK, Lowenthal RM, Garson OM, Cobcroft RG, Dodds AJ, Enno A, Gillett EA, Hermann RP, Joshua DE, Ma DD, Szer J, Taylor KM, Wolf M, Bradstock KF; Australian Leukemia Study Group.

Br J Haematol. 2001 Jun;113(3):727-36.

PMID:
11380464
16.
17.

Lymphoma at uncommon sites.

Young GA.

Hematol Oncol. 1999 Jun;17(2):53-83. Review.

PMID:
10521869
18.

Myelofibrosis presenting as splenic tumor.

Macumber C, Phan TG, Young GA, Selby WS.

Dig Dis Sci. 1999 Sep;44(9):1817-22. No abstract available.

PMID:
10505720
19.

A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG).

Lowenthal RM, Bradstock KF, Matthews JP, Bishop JF, Juneja S, Cobcroft R, Eliadis P, Enno A, Gill D, Herrmann RP, Manoharan A, Page FJ, Rooney KF, Rosenfeld D, Seldon M, Taylor KM, Wolf MM, Young GA.

Leuk Lymphoma. 1999 Aug;34(5-6):501-10.

PMID:
10492073
20.

Characterisation of erythrocyte shapes and sizes by NMR diffusion-diffraction of water: correlations with electron micrographs.

Torres AM, Michniewicz RJ, Chapman BE, Young GA, Kuchel PW.

Magn Reson Imaging. 1998 May;16(4):423-34.

PMID:
9665553
21.
22.

Neurology and the bone marrow.

Pollard JD, Young GA.

J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):706-18. Review. No abstract available.

23.

Increased plasma leptin/fat ratio in patients with chronic renal failure: a cause of malnutrition?

Young GA, Woodrow G, Kendall S, Oldroyd B, Turney JH, Brownjohn AM, Smith MA.

Nephrol Dial Transplant. 1997 Nov;12(11):2318-23.

PMID:
9394318
24.

The narrative skills of primary school children with a unilateral hearing impairment.

Young GA, James DG, Brown K, Giles F, Hemmings L, Hollis J, Keagan S, Newton M.

Clin Linguist Phon. 1997;11(2):115-38. doi: 10.1080/02699209708985186.

PMID:
21271754
25.

Effects of cytosine arabinoside on human leukemia cells.

Crisp LB, Smith SM, Mathers MA, Young GA, Lyons SD, Christopherson RI.

Int J Biochem Cell Biol. 1996 Sep;28(9):1061-9.

PMID:
8930129
26.

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

Bishop JF, Matthews JP, Young GA, Szer J, Gillett A, Joshua D, Bradstock K, Enno A, Wolf MM, Fox R, Cobcroft R, Herrmann R, Van Der Weyden M, Lowenthal RM, Page F, Garson OM, Juneja S.

Blood. 1996 Mar 1;87(5):1710-7.

27.

Thalidomide responsive chronic pulmonary GVHD.

Forsyth CJ, Cremer PD, Torzillo P, Iland HJ, Young GA.

Bone Marrow Transplant. 1996 Feb;17(2):291-3.

PMID:
8640183
28.
29.

D-Amino acids in chronic renal failure and the effects of dialysis and urinary losses.

Young GA, Kendall S, Brownjohn AM.

Amino Acids. 1994 Oct;6(3):283-93. doi: 10.1007/BF00813748.

PMID:
24189736
30.
31.
34.

Interactions between U-50,488H and sigma receptor antagonists: EEG, EEG power spectral and behavioral correlates.

Young GA, Hudson GM, Stamidis H, Steinfels GF.

Eur J Pharmacol. 1993 Feb 16;231(3):473-6.

PMID:
8095467
35.
37.

Complement activation during CAPD.

Young GA, Kendall S, Brownjohn AM.

Nephrol Dial Transplant. 1993;8(12):1372-5.

PMID:
8159307
38.

Cholecystokinin octapeptide alters morphine-induced effects on EEG power spectra both quantitatively and qualitatively.

Hudson GM, Marquis KL, Stamidis H, Young GA.

Eur J Pharmacol. 1992 Oct 20;221(2-3):217-22.

PMID:
1426001
39.
40.
41.
42.

Naltrindole retards tolerance development to morphine-induced effects on EEG and EEG power spectra.

Stamidis H, Young GA.

Eur J Pharmacol. 1992 Mar 17;213(1):9-16.

PMID:
1499659
43.

An unusual cutaneous lymphoma with B and T cell characteristics showing gallium-67 positive benign thymic hyperplasia following intensive chemotherapy.

Young GA, Grace J, Williams BG, Trent RJ, McLaughlin AF, McCaughan B.

Aust N Z J Med. 1991 Aug;21(4):447-50.

PMID:
1659360
44.

Amino acids and the kidney.

Young GA.

Amino Acids. 1991 Jun;1(2):183-92. doi: 10.1007/BF00806915.

PMID:
24194102
45.

Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity.

Paquette NC, Young GA.

Eur J Pharmacol. 1991 Apr 10;196(1):61-7.

PMID:
1678713
46.

Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study.

Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, Castelnova C, Oreopoulos DG, Anderson GH, Bergstrom J, et al.

Am J Kidney Dis. 1991 Apr;17(4):462-71.

PMID:
1901197
47.

Salmonella empyema in a patient with lymphoma.

Cistulli PA, Barnes DJ, Young GA.

Aust N Z J Med. 1991 Apr;21(2):246-7.

PMID:
1872755
48.

Long-term effects of biofeedback-induced facial relaxation on measures of asthma severity in children.

Kotses H, Harver A, Segreto J, Glaus KD, Creer TL, Young GA.

Biofeedback Self Regul. 1991 Mar;16(1):1-21.

PMID:
2012823
49.

Late Relapses in Hodgkin's Disease: Are They a Distinct Entity?

Young GA, Perkins AC, Iland HJ, Vincent PC, Kulkarni A.

Leuk Lymphoma. 1991;4(5-6):363-9. doi: 10.3109/10428199109068087.

PMID:
27467669
50.

Effect of intrarenal renin inhibition on renal hemodynamics and excretory function.

Verburg KM, Kadam JR, Young GA, Rosenberg SH, Kleinert HD.

Am J Physiol. 1990 Jul;259(1 Pt 2):R7-14.

PMID:
2197881

Supplemental Content

Loading ...
Support Center